C.Surgical Procedure; Cardiac Clinical Trial
Official title:
Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA Study)
Describe the proportion of patients who underwent cardiac surgery in France and benefiting from a monitoring cardiac output, describe the use of positive inotropic and vasoactive agents for cardiac surgery patients operated (type of catecholamines, their duration), describe the fluid replacement and transfusions of first 24 hours, describe the incidence of postoperative complications in patients undergoing cardiac surgery.
The perioperative management in cardiac surgery patients has changed dramatically in the last
fifteen years with the development of new cardiac output monitoring devices, the availability
of new inotropic molecules, and a modern treatment for cardio-circulatory failure.
However, few studies report the possible changes in practice. The last French national survey
was conducted in 2001. Since then, the literature is poor on the subject, and the impact of
new approaches has been only marginally addressed. Recently, a German postal survey was
conducted among cardiac surgery anesthesiologists, but on purely declarative elements and
without patient data.
The investigators offer a type of national prospective observational study to evaluate
professional practices, morbidity and mortality in cardiac surgical patients. This study must
include all patients undergoing cardiac surgery at the participating centers during 7 weeks.
The main objective of this work is to assess the proportion of patients undergoing cardiac
surgery receiving a cardiac output monitoring.
Secondary objectives are to describe the relationship between the use of cardiac output
monitoring and the use of positive inotropic agents and vasoactive (type molecules,
duration), volume expansion and transfusions the first 24 hours, and the incidence
postoperative complications for patients undergoing cardiac surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02908009 -
A Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery
|
||
Completed |
NCT01998438 -
Prospective Trial of Tranexamic Acid in Cardiac Surgery
|
Phase 4 | |
Completed |
NCT01805466 -
Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO)
|
N/A | |
Completed |
NCT02658006 -
Evaluation of Monitoring TECHNOlogies in the PERI-OPerative Care of Cardiac Surgical Patients
|
N/A | |
Completed |
NCT02267538 -
Dexmedetomidine and Delirium in Patients After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT02866825 -
Studying Complement Inhibition in Complex Cardiac Surgery
|
Phase 2 | |
Completed |
NCT02513862 -
Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery
|
N/A | |
Completed |
NCT02560519 -
Albumin in Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT03884725 -
Fibrinogen Concentrate In Children Cardiac Surgery 2
|
Phase 4 | |
Recruiting |
NCT01879475 -
Safety and Performance of 032-11 Haemostat in Cardiac and Thoracic Aortic Surgery
|
N/A | |
Completed |
NCT00598195 -
Ketamine Pharmacokinetics in Children Having Heart Surgery
|
N/A | |
Completed |
NCT02972684 -
Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass
|
N/A | |
Recruiting |
NCT02560285 -
High-risk Patients in Cardiac Surgery Procedures: HiriSCORE
|
N/A | |
Terminated |
NCT02793895 -
Detection of Atrial Fibrillation After Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT03343418 -
Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery
|
Phase 4 | |
Recruiting |
NCT03469440 -
Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery
|
N/A | |
Recruiting |
NCT03882593 -
Blood Cell Adhesion to Arterial Filters During Cardiac Surgery
|
||
Withdrawn |
NCT02119806 -
Decreasing the Incidence of Delirium After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT02831907 -
Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Recruiting |
NCT02745951 -
HELIox CardiOPlegia Trial During Cardiac surgERy
|
N/A |